- Home
- OPK vs CRNX Comparison
OPK vs CRNX Comparison
Compare OPK & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- CRNX
- Stock Information
- Founded
- OPK 2007
- CRNX 2008
- Country
- OPK United States
- CRNX United States
- Employees
- OPK N/A
- CRNX N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- CRNX Health Care
- Exchange
- OPK Nasdaq
- CRNX Nasdaq
- Market Cap
- OPK N/A
- CRNX 2.8B
- IPO Year
- OPK 1995
- CRNX 2018
- Fundamental
- Price
- OPK $1.38
- CRNX $31.88
- Analyst Decision
- OPK Buy
- CRNX Strong Buy
- Analyst Count
- OPK 4
- CRNX 10
- Target Price
- OPK $2.75
- CRNX $75.00
- AVG Volume (30 Days)
- OPK 3.5M
- CRNX 942.0K
- Earning Date
- OPK 04-30-2025
- CRNX 05-08-2025
- Dividend Yield
- OPK N/A
- CRNX N/A
- EPS Growth
- OPK N/A
- CRNX N/A
- EPS
- OPK N/A
- CRNX N/A
- Revenue
- OPK $689,408,000.00
- CRNX $760,000.00
- Revenue This Year
- OPK N/A
- CRNX $343.70
- Revenue Next Year
- OPK $7.74
- CRNX $733.93
- P/E Ratio
- OPK N/A
- CRNX N/A
- Revenue Growth
- OPK N/A
- CRNX N/A
- 52 Week Low
- OPK $1.19
- CRNX $24.10
- 52 Week High
- OPK $2.04
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- OPK 53.94
- CRNX 53.86
- Support Level
- OPK $1.23
- CRNX $29.22
- Resistance Level
- OPK $1.34
- CRNX $30.99
- Average True Range (ATR)
- OPK 0.05
- CRNX 1.40
- MACD
- OPK 0.02
- CRNX 0.04
- Stochastic Oscillator
- OPK 78.95
- CRNX 64.17
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.